The in vivo kinetics of the dopamine (DA) transporter probe 1 2 3 I-labeled 2r3-carboxymethoxy-3r3-(4iodophenyl)tropane ([1 2 3 1]r3-CIT) in striatum was investi gated with single-photon emission computerized tomog raphy (SPECT) in five healthy human subjects. The aim of this study was to derive an adequate measure of the DA transporter density that would not be affected by re gional cerebral blood flow or peripheral clearance of the tracer. SPECT data were acquired on the day of injection (day 1) from 0 to 7 h and on the following day (day 2) from 19 to 25 h. Arterial sampling on day 1 was used to mea sure the input function. Graphical, kinetic, and equilib rium analyses were evaluated. Graphical analysis of day 1 data, with the assumption of negligible dissociation of the tracer-receptor complex (k4 = 0), was found to be blood flow-dependent. A three-compartment kinetic analysis of day 1 data were performed using a three (k4 = 0)-and a four (k4 > O)-parameter model. The three-parameter 2[3-Carbomethoxy -3 [3-( 4-iodophenyl)tropane ([3-CIT; also referred to as RTI-55) is a potent cocaine analogue with a high affinity for the dopamine (DA) and serotonin (5-HT) transporters (Carroll et aI., 1991; Neumeyer et aI., 1991) . [ 1 23 I] [3_CIT has been shown to be a promising single-photon emission
model estimated the konBmax product at 0.886 ± 0.087 min -1 . The four-parameter model gave a binding poten tial (BP) of 476 ml g-l , a value consistent with in vitro measurements. The stability of the regional uptake on day 2 allowed direct measurement of the specific to nonspe cific equilibrium partition coefficient (V 3 " = k31k4 = 6.66 ± 1.54). Results of day 1 kinetic analysis and day 2 equi librium analysis were well correlated among subjects. Simulations indicated that the error associated with the day 2 equilibrium analysis was acceptable for plasma tracer terminal half-lives > 10 h. We propose the equilib rium analysis on day 2 as the method of choice for clinical studies since it does not require multiple scans or the measurement of the arterial plasma tracer concentrations. Key Words: Dopamine transporter-1 2 3 I-Labeled 2r3carboxymethoxy-3r3-( 4-iodophenyl)tropane-Parkinson' s disease-RTI-55-Single-photon emission computed to mography-Tracer kinetic model. computerized tomography (SPECT) tracer for visu alization of DA and 5-HT transporters (Laruelle et aI., 1993b) . In primates, the tracer concentrated over time in the striatal and midbrain regions. Phar macological characterization of the regional uptake demonstrated that the striatal activity was associ ated with DA transporters, while the midbrain ac tivity was associated with 5-HT transporters (Laruelle et aI., 1993b) .
Initial studies in human subjects confirmed the high and prolonged levels of activity in striatum (Briicke et aI., 1993; Innis et aI., 1993; Kuikka et aI., 1993) . In five patients with idiopathic Parkinson's disease, the tracer uptake in the striatum was sig nificantly decreased compared to that in five age matched healthy controls (Innis et aI., 1993) . The patient striatal-to-occipital activIty ratio was re duced to 60 to 70% of the control values 4 h postin jection and to 30 to 40% 22 h postinjection. Thus, e 23 I]ip-CIT SPECT imaging appears to be a prom ising technique for the diagnosis and evaluation of Parkinson's disease.
In these initial experiments, several outcome measures were studied at various time points postinjection: the striatal activity, the striatal-to occipital activity ratio, the striatal-to-plasma activ ity ratio, and the striatal rate of uptake measured by graphical analysis. These outcome measures pro vided different estimates of the severity of DA neu ronal loss. It was unclear which one, if any, would provide an accurate assessment of the DA trans porter density without being influenced by regional cerebral blood flow or tracer peripheral clearance rate. This question could not be appropriately ad dressed by compartment modeling because of the limited number of scans acquired per studies. In the present work, we collected more extensive data sets to evaluate model-based methods for measure ment of the DA transporter density in humans with [1 23 I] ip_CIT .
Model-based methods characterize the brain re gional response to an arterial input function and provide quantitative estimation of receptor param eters (Carson, 1986; Gjedde and Wong, 1990) . They usually require arterial sampling and repeated scans, procedures that are not easily implemented in a clinical setting. However, model-based meth ods provide a framework against which simple, em pirical methods can be evaluated.
In healthy humans, e 23 I] f3-CIT striatal activity in creases at an apparent constant rate for at least 5 h after injection. However, displacement experi ments clearly showed that the binding of [1 23 1] ip_CIT is reversible (Laruelle et a\., 1993b) . Thus, e 23 I]ip CIT falls within the category of slowly equilibrating neuroreceptor probes. This pattern of uptake is typ ically observed with tracers that are cleared slowly from the blood and bind with a high affinity (slow dissociation) to sites present at a high density. An alysis of experimental data from slowly reversible tracers presents special problems regarding the site quantification, as the peak uptake of the specific binding is not reached within the usual time frame of the experiment.
The binding potential (BP) is a frequently used outcome measure for experiments performed with rapidly equilibrating tracers (Mintun et aI., 1984) and corresponds to the product of the site density (Bmax) and affinity (1/K D ' where K D is the equilib riUlil dissociation constant of the receptor-ligand complex). If equilibrium is not observed during the experiment, the BP cannot be reliably measured (Gjedde and Wong, 1990) . In these situations, the rate of binding to the receptors (i.e., the konBmax product, where kon is the association rate constant) can be used as the outcome measure (Wong et aI., 1986; Logan et a\., 1991) .
A graphical technique has been introduced by Gjedde (1981) and generalized by Patlak et ai. (1983) for determination of the rate of uptake into an irre versible compartment (Kin)' We included this anal ysis in our previous work as a potential outcome measure for e 23 I]ip-CIT experiments . However, the usefulness of the graphical analysis rests on the sensitivity of Kin to Bmax and blood flow, respectively (Logan et aI., 1991) . In the present study, early time points were acquired to evaluate with kinetic modeling the relationships among Kin, Bmax, and blood flow.
The longer half-life of the SPECT isotope 1 23 1 (13 h) as opposed to the PET isotopes e1C, 20 min; 1 8 F, 110 min) allowed us to study the kinetics of uptake for 24 h postinjection. In the present study, five healthy volunteers were injected with e 23 I]ip-CIT and scans were acquired intermittently for 7 h after injection (day 1 of the study) and from 19 to 25 h after injection (day 2). Day 1 data were analyzed with kinetic and graphical methods. The inclusion of day 2 data allowed equilibrium analysis and der ivation of BP.
METHODS

Radiolabeling
r1 2 3 Il�-CIT was prepared from the corresponding trim ethylstannyl precursor as described previously (Baldwin et aI., 1993) . [1 2 3 Il�-CIT was obtained in an average ra diochemical yield of 56.6 ± 10.5% (n = 5, with this and subsequent values expressed as mean ± SD), a radio chemical purity of 98.0 ± 0.8%, and a specific activity of >50,000 Cilmmol.
Healthy subjects
Five healthy subjects (one female and four males; age, 30 ± 9 years; weight, 65 ± 11 kg) participated in these studies. Inclusion criteria were (a) the absence of any current medical condition and (b) the absence of present or past neuropsychiatric illnesses or alcohol or substance abuse. Physical examination, ECG, and routine blood and urine tests were performed in the screening proce dure. All subjects gave written informed consent to the research protocol approved by the local human investi gation committee. Subjects received 0.6 g potassium io dide (SSKI solution) in the 24 h prior to the scan.
Datum acquisition
SPECT data were acquired with the multi slice brain dedicated CERASPECT camera (Digital Scintigraphies, Waltham, MA, U.S.A.), with a transaxial and axial res olution of 7. 7-and 5.9-mm full width at half-maximum, respectively. Before each set of continuous acquisitions (8 to 10 times per study), an 1 2 3 1 point source (104 ± 59 fLCi) was positioned in the center of the field of view for sensitivity evaluation. The mean point source sensitivity was 5,742 ± 436 cps/mCi. No between-experiment signif icant differences in the point source sensitivity of the camera were observed during this study. Four fiducial markers filled with 10 fLCi of Na99mTc04 were glued on each side of the subject's head at the level of the cantho meatal plane to control for adequate positioning of the subject's head in the gantry before tracer injection and to identify the canthomeatal plane during image analysis. A catheter was inserted in the radial artery for blood sam pling.
[1 2 3 I]�_ClT (9.5 ± 1 mCi) was injected as a single bolus over 30 s at approximately 3:00 PM (day 1). Immediately after injection, scans were acquired according to the fol lowing protocol: four scans of 3 min, followed by four scans of 6 min, then four scans of 10 min. After this initial session (9 1 -min total duration), the subjects were allowed to rest out of the gantry for 45 min. Two scans of 10 min were then acquired every 45 min up to 420 min postinjec tion 00:00 PM). The next day (day 2), scans of 20-min duration were acquired every hour from 1,140 min (19 h; 10:00 AM on day 2) to 1,500 min (25 h, 4:00 PM on day 2).
A total of 30 acquisitions was thus obtained for each study.
On day 1, arterial samples were obtained every lOs for the first 2 min with a peristaltic pump (Harvard 250 1-001, South Natick, MA, U.S.A.). Subsequent samples were obtained manually at 3, 4, 6, 8, 10, 12, 16, 20 , and 30 min and every 30 min until 420 min. No arterial samples were collected on day 2 because of difficulties associated with the second placement of an arterial catheter.
Arterial plasma analysis
Arterial samples were analyzed as described previously (Baldwin et aI., 1993) . Extraction in ethyl acetate was followed by reverse-phase HPLC to measure the metab olite-corrected total plasma activity [C a(t); fLCi/ml]. Plasma protein binding was measured in vitro by ultrafil tration through four Centrifree membrane filters (Ami con, Beverly, MA, U.S.A.) in quadruplicate at 37"C as described previously (Gandelman et aI., 1994) . The free, metabolite-corrected plasma activities were fit to a sum of three exponentials,
where f l (unitless) is the free fraction of the parent com pound in the plasma, Co (fLCi/ml) is the peak plasma con centration, ai (unitless) are the relative zero-time inter cepts of each exponential, and Ai (min -I ) are the elimi nation rate constants associated with each exponential. The terminal half-life of the tracer in the plasma (T 3 ; min) was calculated as In(2)/A 3 . The initial volume of distribu tion of the free tracer, Vbol (L), was calculated as the ratio of the injected dose (mCi) to f I Co (mCi/L). The plasma clearance (CL; Uhr) was calculated as the ratio of the dose (mCi) to the total area under the curve of the tracer time-activity curve (mCi h L -I) as described previously (Laruelle et aI., 1994b) .
Image analysis
Images were reconstructed, filtered, attenuation cor rected, and reoriented as described previously (Abi-J Cereb Blood Flow Metab, Vol. 14, No.6, 1994 Dargham et aI., 1994). The four slices corresponding to the highest striatal activity were summed. Three regions of interest were positioned on this summed image at the level of the right and left striatum (1,070 mm 2 each) and occipital pole (2,746 mm 2 ). Activities from right and left striatum were averaged. Average regional activities (cpml cc) were decay corrected for the time of injection and expressed as microcuries per cubic centimeter using a calibration of factor of 0.0045 fLCi/cpm. This factor was calculated as the average calibration factor derived from three 1 2 3 1 distributed source experiments 03-cm diame ter, filled with 845 ml of 0.2 fLCi/ml solution) acquired during the period of the study using the same protocol. No attempts were made to correct for partial volume ef fects or for the scatter fraction of the photopeak window. In our preliminary work with [1 2 3 I]�_CIT in humans (Innis et aI., 1993) , we used an algorithm supplied by the camera manufacturer to remove the scatter from the high-energy emission of 1 2 3 1. This algorithm induces an increase in the activity in the center of the field of view compared to the periphery. As this algorithm was not used in the present study, the data presented here cannot be compared di rectly with our previous results.
Derivation of receptor parameters
Theory. A three-compartment model was used to ana lyze time-activity curves in the striatum. The model in cluded the arterial plasma compartment (Ca), the intrace rebral rapidly reversible compartment (C 2 ; also desig nated the npndisplaceab\e compartment), and the slowly reversible compartment (C 3 ; also designated the specific compartment), C 2 included the free, the nonspecific bind ing and the binding to the 5-HT transporters (shown to equilibrate much faster than the binding to the DA trans porters) (Laruelle et aI., 1993b) . In the occipital region where DA uptake sites are not detectable (Marcusson and Erikson, 1988; De Keyser et aI., 1989 ), a two-compart ment model was used.
The equilibrium distribution volume of a compartment i ( Vi; ml g-I ) was defined as the equilibrium ratio of the tracer concentration in this compartment to the free ar terial concentration,
(2) V2 and V 3 are the equilibrium distribution volumes of the second and third compartment, respectively. V T is the total regional equilibrium distribution volume, equal to the sum of V 2 and V 3 . The specific-to-nonspecific equi librium partition coefficient, V 3 " (unitless), was defined as the equilibrium volume of distribution of C 3 relative to C 2 ,
The tracer concentration over time in C 2 and C 3 was given by (5) The kinetic parameters were defined as follows:
where F (ml g -I min -I) is the regional blood flow, E (unitless) is the unidirectional extraction fraction, PS (ml g -I min -I) is the permeability surface area product of the tracer, kon (nM-I min -I ) is the bimolecular ligand receptor association rate constant, Bmax' (nM) is the con centration of receptors available for binding (equal to Bmax since experiments were performed at tracer doses), and koff (min -I) is the receptor dissociation rate constant. The relationship between volumes of distribution and rate constants were given by setting the derivatives to zero in Eqs. 4 and 5.
(10)
Substituting in Eq. II the terms K/k-j' l, k3, and k4 with Eqs. 7, 8, and 9, respectively, and recalling that KD is equal to k O frlkon established the equivalence between V3 and BP. The relationships between V3" and the rate con stants were obtained by dividing Eq. 10 by Eq. II.
Comparing Eqs. II and 12 underlines that the k31k4 ratio, i.e., V3'" should not be confused with the BP. The contribution of the activity in the blood vessels to the total regional activity, estimated using the total blood activity integrated over the acquisition time and a mean blood volume equal to 5% of the regional volume (Mintun et aI., 1984) , was found to be negligible «0.5%). Thus, regional activity at time t[C(t)] was given by (13) Under tracer conditions, Eq. 13 can be solved analyt ically as the convolution of the input function, Ca(t), with the impulse response function, which is a sum of two exponentials (Phelps et aI., 1979) .
where <X i and Ai are given by
In the occipital region, k3 and k4 were set to zero. Thus Eqs. 15 and 16 became (17) (18) and the occipital concentration at time t was given by (19) For irreversible ligands or during the initial uptake of a slowly equilibrating ligand, k4 = O. Under these condi tions, Eqs. 15, 16, and 14 became
The konBmax product was then obtained using Eqs. 10 and 8. Equation 22 was used to generate the equivalence be tween this kinetic model and the graphical analysis. Pro viding that �n «< kz, there is a time t* such that when t > t*, the ratio of the concentration in the second com partment to the plasma concentration will be constant and equal to A I /<X I (Patlak et aI., 1983) . Thus, for t > t*,
substituting Eqs. 20 and 21 in Eq. 22,
Dividing both sides of Eq. 23 by ilCa(t) and expressing the normalized time nCa/Ca(t) as e, the total distribution volume in the striatum for times t > t* was given by Thus, for t > t*, the graph of Vet) versus e will be linear with a slope (Kin) and an intercept (steady-state volume of distribution of the precursor pool, Vzss) equal to , 1981; Patlak et aI., 1983) .
Datum analysis steps. Data were analyzed in four steps ( Table 1 ).
The first step (graphical analysis) was to inspect the graph of Vet) versus e and to calculate the slope and the intercept of the linear portion of the curve. Integrations were performed numerically using a recursive Simpson's rule.
The second step (kinetic analysis with k4 = 0) was to fit the occipital day 1 data to Eq. 19 and the striatal day 1 data to Eq. 22, i.e., under the assumption that k4 = O.
This kinetic analysis was thus the kinetic counterpart of the graphical analysis. Nonlinear regression was per formed as previously described (Laruelle et aI., 1994b) . Two fitting strategies were used (referred to as fits A and B). In fit A, no constraints were used in the parameter estimation. In fit B, the value of the Kllkz ratio in the 
Kin (ml g-I min -I ), rate of tracer transfer from the precursor to the receptor compartment; konBmax (min -I ), product of receptor association rate constant (k o n; min -I nM -I ) and receptor density ( Bmax ; nM); V 3 " (unitless), specific-to-nonspecific equilibrium partition coefficient; k 4 (min -I ), receptor dissociation rate constant; BP (ml g -I ).
striatum was constrained to the value of the K I Ik2 ratio in the occipital. As both K\ and k2 include the regional blood flow, this constraint was not a constraint on the flow value but on the equilibrium distribution volume of the nonspecific compartment (V2).
The third step (equilibrium analysis) was to inspect the day 2 time-activity curves. The stability of the striatal and occipital uptake suggested that a state of equilibrium was achieved during day 2. Therefore, the average C3(t)1 C2(t) ratio over the day 2 session was used as a measure of V3" ( = k31k4 ratio; Eq. 12). BP was calculated with Eq. 11 as the product of k31k4 (day 2) and K/kJ\ (day I) .
The fourth step (kinetic analysis with k4 > 0) consisted in two additional kinetic fits of the day 1 striatum data that incorporated information obtained in the third step. Two fitting strategies were sequentially implemented (fits C and D). In fit C, the k31k4 ratio was constrained to the V3" value measured on day 2. The main purpose of this kinetic analysis was to derive the value of k4• Fit D con sisted in fitting data from day 1 with the value of k4 con strained to the average k4 value as derived from fit C. In both fits C and D, the value of the Kllk2 ratio in the striatum was constrained to the value of the K I I k2 ratio in the occipital.
Evaluation of fitting strategies. Three criteria were used to assess the quality of a model.
(1) Identifiability of the parameters. The standard er rors of the parameters were given by the diagonal of the covariance matrix (Carson, 1986 ) and expressed as a percentage of the parameters (coefficient of variation; %cv). (2) Goodness-of-fit. Akaike's (1974) information crite- Vb o l' initial plasma volume of distribution of the free tracer; CL, plasma clearance of the free parent compound; � 3 ' smallest plasma elimination rate constant; T 3 , terminal half-life of the plasma c1earance;!l, free fraction of the parent compound in the plasma.
J Cereb Blood Flow Metab, Vol. 14, No.6, 1994 ria (AlC) were used to compare the goodness of fit of models with different levels of complexity.
(3) Sensitivity of the outcome measure to duration of experiment. Beyond a given time, the outcome measure should become independent of the dura tion of the experiment. The stability over time of fits A, B, and D was assessed by fitting data for variably shorter intervals to the different models and expressing the outcome measure as a percent age of the value derived at 420 min postinjection.
RESULTS
Plasma analysis
Results of plasma analysis are listed in Table 2 . Peak plasma activity occurred between 45 and 60 s. The mean V b o 1 (255 ± 74 L) was considerably higher than the plasma volume (2 to 4 L), indicating that the tracer underwent a considerable and rapid dis tribution outside of the plasma. Plasma free concen tration exhibited a sharp decrease during the first 100 min of the study (tissue redistribution phase) and a slow decrease thereafter (metabolism phase; Fig. 1 ). Pharmacokinetic parameters of the plasma clearance of the free parent compound were esti mated by fitting the data to a sum of one, two, mCi in a 24-year"old female (study 2). Measured values (filled circles) were fit to a sum of three exponentials (solid line).
The clearance was calcul jl-ted as 113 Uh. The plasma con centration exhibited a sharp decrease during the first 2 h of the study (tissue redistribution phase) and a slow decrease thereafter (reduction of less than 1%/h after 240 min).
three, and four exponentials. A sum of three expo nentials was selected by F tests (Landlaw and Di Stefano, 1984) . As predicted by the nearly constant levels of plasma tracer after 100 min, the terminal rate constant (;\ 3 ) was small (0.0008 1 ± 0.00022 min -I) and poorly identified (mean %cv on ;\ 3 was 65 ± 63%).
Brain analysis
Activity concentrated over time in the striatum and midbrain areas (Fig. 2) . The striatal activity in creased throughout day 1 (420 min). On day 2, stri atal activity had reached a plateau. The occipital activity exhibited an early peak at approximately 30 to 45 min, then decreased and stabilized between 100 and 200 min postinjection. On day 2, occipital activity was stable at the level reached by end of day 1. The midbrain activity increased for the first 200 min and then stabilized. The cerebellar time activity curve was similar to the occipital time activity curve.
Graphical analysis of day 1 data (first step). The occipital and striatal distribution volumes were plotted versus the normalized time and a linear re gression was performed from 200 to 700 min (cor responding to 120 to 480 min of real time; Fig. 3A and Table 3 ). In the occipital region, the distribution volume increased until 200 to 300 min of normalized time and stablized thereafter. The slope of the linear portion of the occipital curve was small (0.022 ± 0.028 ml g-I min -I) and the intercept (V2) was 70 ± 18 ml g-l. In the striatum, the distribution volume increased linearly with the normalized time after 200 min (r 2 = 0.96 ± 0.03). The slope of the striatal Time (min)
FIG. 2. Brain regional activity after injection of 10 mCi in a 24-year-old female (study 2). Striatal activity (filled circles) increased during the first day (0 to 500 min). On day 2 (1,100 to 1,500 min), the striatum displayed a stable activity level.
Midbrain activity (open circles) increased for the first 3 h, then displayed stable levels until the end of the experiment.
Occipital activity (open triangles) showed an early peak (30 to 60 min), followed by decreasing levels until stabilization (at approximately 200 min).
regression line (Kin) was 0.431 ± 0.59 ml g-I min-I and the intercept (V2ss) was 78 ± 24 mllg. Thus, graphical analysis was compatible with a stable rate of increase of striatal activity from 2 to 8 h after injection, i.e., with a negligible k4• Kinetic analysis with k4 = 0 (second step). Oc cipital time-activity curves were fitted to a two- 1113-CIT in an 18-year-old male (study 4; f 1 = 0.465) . A: Graphical analysis. Measured occipital and striatal total distribution volumes (circles) were plotted versus the nor malized time. The intercepts and slopes of the linear portion of the curves (from 200 to 800 min of normalized time) were obtained by linear regression (solid lines). The occipital slope (0.017 ml g -1 min -1) was much lower than the striatal slope (Kin = 0.446 ml g-1 min-1). The occipital intercept, corresponding to the occipital equilibrium distribution vol ume (V2), was 75 ml g-1. The striatal intercept, correspond ing to the steady-state volume of distribution of the precursor compartment (V2SS)' was 51 ml g -1. B: Kinetic analysis (fit A). The same data set was analyzed by kinetic compartment modeling (circles are measured regional activity and solid lines are fitted values). A two-compartment model was used in the occipital and yielded a K 1 value of 0.376 ml g-1 min-1, a k2 value of 0.0109 min -1, and a V2 value of 74 ml g -1. Thus kinetic and graphical derivation of V2 yielded identical re sults. The striatum was fitted to a three-compartment model, with k4 constrained to zero, and the following kinetic param eters were obtained: K 1 = 0.479 ml g-1 min-1, k2 = 0.00662 min -1, and k 3 = 0.00509 min -1. Calculating Kin as the ratio K 1 k 3 /(k2 + k 3 )f 1 yielded a value of 0.447 ml g -1 min -1, a value identical to the graphically derived Kin' The konBmax product was calculated as 0.791 min-1. compartment model (Fig. 3B) . The mean values of K I and k2 were 0. 365 ± 0.080 ml g-I min -I and 0. 0130 ± 0. 0029 min -I, respectively. The kineti cally derived occipital V2 (70 ± 7 ml g-I) was sim ilar to the intercept of the occipital Patlak slope (70 ± 18 ml g-I).
In the striatum, fit A yielded a V2 value of 204 ± 66 ml g-I, a Kin of 0.436 ± 0.093 ml g-I min -I, and a k onBmax product of 0. 770 ± 0. 202 min -I (Table 3 and Fig. 3B ). Thus, the Kin parameter derived from kinetic analysis was similar to the slope of the linear portion of the Patlak plot (0.43 1 ± 0. 059 ml g -1 min -I). Fit B (Table 4 ) yielded slightly higher Kin (0. 533 ± 0.072 ml g-I min -I) and k o nBmax products (0. 886 ± 0. 087 min -I) than fit A. No statistically significant differences in Ale were observed be tween fit A and fit B (fit A, -350 ± 23; fit B, -343 ± 24; paired t test, p = 0.41). Fit A was affected by a poor identifiability of k2 and k3 (K I ' 5 ± 1 %cv; k 2 ' 25 ± 7%cv; k 3 , 36 ± 26%cv), whereas both param eters of fit B were well identified (K I ' 6 ± 2%cv, k 3 ' 7 ± l%cv).
For both fits, a shorter experiment duration would have resulted in higher estimates of k o nBmax (Fig. 4) . A minimum experimental length of 300 min was required to obtain values within 20% of the final value. However, the SD of the k o nBmax esti mate at different times were much larger for fit A Kinetic analysis (fit A) (Table 4 ) were used to evaluate the dependence of Kin on the blood flow (K 1 and k2) and the receptor density (k 3 ). A blood flow value of 0. 65 ml g-I min -I was used for this analysis (Mazziotta and Phelps, 1986) . By Eq. 6, the K I value of 0. 547 ml g -1 ml-1 estimated the extrac tion fraction (E) as 0. 84 and the PS product as 1. 19 ml g -1 ml-I. U sing this value of PS, values of K I and E at different levels of flow were calculated (Fig. 5A) . The relationship between blood flow and Kin was evaluated with Eq. 25 (Fig. 5B ), calculating k2 with Eq. 7 and keeping k 3 constant. The relation ship between receptor density and Kin was calcu lated by changing the k3 value while keeping K I and k2 constant (Fig. 5B) . As predicted by Eq. 25, these relationships were hyperbolic. At control values, the derivation of Kin as a function of flow and re ceptor density was 0. 28 and 0. 64, respectively. Thus, the impact of flow on Kin was not negligible and the relationship between Bmax and Kin had a slope far from unity.
Equilibrium analysis of day 2 data (third step). Striatal activity plateaued at levels lower than pre dicted by projections from day 1 graphical analysis, indicating that k4 was not strictly equal to zero. Both occipital and striatal activities exhibited re markable stability over the course of day 2 (Table  5 ). This observation allowed us to use the average day 2 C 3 (t)/C 2 (t) ratio as a measure of V3" (6. 66 ± 1.54). A significant linear relationship (?-= 0. 83, p < 0.005) was noted between V3" (day 2) and k3 (day 1, fit B). Combining data from days 1 and 2, Eq. 11 allowed calculating BP as 462 ± 62 ml g-I (Table 5) . As this BP value was consistent with both day 1 and day 2 data, it was considered the reference BP in the evaluation of fit D.
Kinetic analysis of striatum with k4 > 0 (fourth step). Fit C provided estimates of four kinetic pa rameters compatible with data sets from both days: K1, 0.497 ± 0. 115 ml g-I min -I; k2' 0. 0175 ± 0. 0034 min -I; k3' 0. 0250 ± 0. 0059 min -I; and k4' 0. 00386 ± 0.0009 1 min -I. The small k4 value indicated a prolonged ligand-receptor dissociation half-life (180 ± 24 min). Since this set of four parameters was consistent with data from both days, it was consid ered as the reference and used in simulations .
The possibility of deriving BP values from day 1 data was investigated by fixing k4 in each subject to the average value of k4 derived by fit C (0.00386 min -I, fit D; Fig. 6A and Table 6 ). Average values a Regional slopes obtained by liner regression and expressed as percentage mean regional activity on day 2.
b Specific-to-nonspecific equilibrium partition coefficient, cal culated as the average day 2 striatum minus occipital/occipital activity ratio. C Obtained as the product of V2 (from day I) and V 3" (from day 2).
of Kj, kz, and k3 by fit D were similar to the values derived from fit C. The identifiability of K j and k3 by fit D (4 ± 1 and 5 ± I%cv, respectively) was excellent. The goodness of fit as assessed by AIC were identical in fits D ( -353 ± 23) and C ( -351 ± 23). The BP values (476 ± 60 ml g-j ) derived by fit D were similar to reference BP values (462 ± 62 ml g-t). In each of the five subjects, the BP value sta bilized at the final (420-min) BP value at 240 min (Fig. 6B) .
Simulations
A 1440-min input function was created by fitting a typical day 1 plasma curve (experiment 2) while constraining x'3 to the washout rate observed on day 2 in the occipital region (corresponding to a terminal half-life of 50 h): Q I = 0. 687, Q2 = 0. 548, Q3 = 0. 127, x'j = 0. 358 min -I, x'2 = 0.02804 min -t, x'3 = 0.000231 min -I. A typical set of kinetic parameters (study 2, fit C) was used as the striatal impulse re sponse function. "Parkinsonian" striatal time activity curves were simulated by setting k3 to 75, 50, 25, and 10% of the control values, keeping all other parameters constant (Fig. 7) . The Cit)/C2(t) ratios (measured V 3 ") were calculated from 1,200 to 1,440 min and represented 99, 102, 105, 106, and 106% of the true value of V 3 " in the 100, 75, 50, 25, and 10% simulations, respectively. Thus, the recep tor density decrease was measured with an error �6%.
DISCUSSION
The aim of this investigation was to develop a method of data analysis for [1 2 3 I]I3_CIT uptake in the striatum that would provide an outcome mea-J Cereb Blood Flow Metab, Vol. 14. No. 6, 1994 sure (a) linearly related to the density of DA tranS' porters and (b) unbiased by potential intersubject variability in tracer peripheral clearance and re gional cerebral blood flow.
Preliminary [1 2 3 1l 13-CIT SPECT experiments in humans showed that the striatal activity increased during the first 7 h after injection. Thus, striatum to-occipital ratios obtained during day 1 are affected by the tracer peripheral clearance and are not an adequate outcome measure. This observation led us to propose the graphical analysis , in which the input function is normalized so that the outcome measure is not affected by potential be- 1113-CIT in a 41-year-old male (study 3). Occipital activity was fitted to a two-compartment model as in Fig. 3B . Striatal activities were fit to a three-compartment model with k4 constrained at 0.00386 min -\ and the K 1 1k2 ratio constrained to the occip ital V2. This analysis yielded the following set of rate con stants: K 1 = 0.453 ml g -1 min -\ k2 = 0.0164 min -\ k 3 = 0.0227 min-1, and BP = 465 ml g-1. B: Relationship be tween BP by fit D and duration of experiments. Day 1 data were analyzed with fit D for an increasing period of time, from 0 to 120 min to 0 to 420 min. The BP are expressed as a percentage of the 420-min values. Graphs represent the mean ± SD of the five experiments for each experiment du ration. In contrast to results obtained with fits A and B (Fig.  4A and B) , BP reached a stable value at 240 min, after which time increasing the experiment duration did not affect the BP. tween-subject differences in peripheral clearance. This graphical analysis was performed under the assumption of negligible tracer-receptor complex dissociation, which was supported by the apparent linear relationship between the striatal distribution volume and the normalized time. The linearity of this relationship was confirmed in the studies re ported here. However, before adopting this method, it was im portant to specify the relationship between the rate of uptake, Kin, and the receptor density. Kin is lin ear with the receptor density only if the rate of bind ing is the limiting step to the tracer transfer into the "irreversible" compartment. This can be appreci ated by inspection of Eq. 25. When k3 � k2' Eq. 25 simplifies to Kin = (klk3)/(fjk2) and the flow factor, included in both K) and k2' cancels out. At the other 1.6 : § For this purpose, we implemented a kinetic model based on assumptions similar to the Patlak analysis, i.e., k4 = 0 (fits A and B). Kinetic param eters derived from fit B were used to investigate Kin as a potential outcome measure. This analysis re vealed that flow effects on Kin were not negligible. The explicit derivation of k3 (and konBmax) seemed preferable for quantitative analysis of the data.
Yet this solution was not fully satisfactory. De spite the apparent linearity of the Patlak plots, in spection of Fig. 4 revealed that konBmax decreased when the length of the experiment increased, sug gesting that the rate of binding was not strictly con stant over time. Since experiments were performed at tracer doses and negligible receptor occupancy, this observation could not be explained by a recep tor saturation effect. Instead, it suggested that k4 was not strictly equal to zero and that, as the tracer accumulated in the receptor compartment, the dis sociation became nonnegligible. However, includ ing an unconstrained k4 term in the model resulted in an unacceptable poor identifiability of the rate constants and a large time dependence of the pre sumed BP (data not shown).
At this juncture, the data collected on day 2 pro vided important information. First, the striatal ac tivity measured on day 2 was significantly lower than the levels projected by extrapolation of day 1 graphical analysis. This confirmed that the binding was not irreversible, as anticipated from displace ment experiments in primates (Laruelle et aI., 1993b) , and that k4 was not strictly equal to zero.
Second, the regional activities displayed a re markable stability on day 2, reminiscent of the sta bility observed during constant infusion experi ments (Abi-Dargham et aI., 1994; Laruelle et aI., 1994a) . This observation suggested that a state of sustained equilibrium (i.e., stable brain and plasma activities) was achieved during day 2. Although plasma measurements were not obtained during day 2, the stability of the plasma concentration during day 2 could be inferred from both (a) the stability of the plasma concentration at the end of day 1 and (b) the stability of the occipital region, which at time >t* (t* = 120 min), is parallel to the plasma con centration (Patlak et aI., 1983) . Carson et al. (1992) demonstrated both theoretically and experimentally that, if the plasma concentration of a tracer is con stant for a sufficiently long period of time, the re gional activity ratios will become equal to the ratio M. LARUELLE ET AL . of the regional equilibrium distribution volumes. Under these conditions, if a region of reference de void of receptors can be used as a measure of the nonspecific binding, the specific-to-nonspecific ra tio is numerically equal to V3/1 and to the k3/k4 ratio. Thus, the stability of striatal and occipital activities on day 2 suggested that the day 2 C3(t)C2(t) ratio could be used as a measure of V3/1. Based on this observation, we feel that, among the various out come measures proposed in our previous work (In nis et aI., 1993) , the striatum-to-occipital ratios measured during day 2 in the Parkinsonian subjects probably represented the best estimate of the alter ation in DA transporters density.
Third, the value of BP (462 ± 62 ml g -I ) could be derived as the product of V 2 (measured on day 1) and V3/1 (measured on day 2). Comparison with in vitro values is complicated by the existence of high and low-affinity sites of the DA transporter for the cocaine analogues. However, this value of BP is compatible with the in vitro Bmax and the IC 5 0 val ues of [1 2 5 I] [3_CIT for the DA transporter, consider ing the IC 5 0 as an average measure of the affinity for both population of sites. The total density of co caine binding sites related to DA transporter sites in the caudate of primates was estimated as 340 nM with eH]cocaine (Madras et a!., 1989a) , 459 nM with [ 3 H]CFT (Madras et a!., 1989b) , and 478 nM with e 2 5 I]f3-CIT (Laruelle et a!., 1994c) . Using the latter value, a BP of 462 would be compatible with an average affinity of 1.0 nM, a value in accordance with the in vitro IC 5 0 of e 2 5 I][3-CIT for the DA transporter (1.6 nM) measured in primate striatum (Neumeyer et aI., 1991) .
The next fitting strategy (fit C) was performed to yield estimates of the rate constants compatible with data from both days. This analysis yielded an average k o ff value of 0.00386 ± 0.0009 1 min -I . This value was lower than the k o ff value measured in vitro in fresh rat striatal membrane homogenates (0.045 min -I at 22°C and 0. 18 min -I at 3rC) (Laruelle et a!., 1994c) . Similar discrepancies be tween in vitro and in vivo dissociation rates have been reported for other high-affinity tracers and are thought to be related to the synaptic microenviron ment in which the ligand is trapped, leading to an apparent decrease in k o ff (Frost and Wagner, 1984) .
The last fitting strategy (fit D) improved the ki netic model developed for day 1 by the inclusion of a small, nonzero, and fixed dissociation term. BP values by fit D were very close to the reference BP and were insensitive to the length of the experiment for a duration longer than 240 min. The better sta bility over time of BP in fit D compared to k onBmax in fit B reflects the fact that the inclusion of a small J Cereb Blood Flow Metab, Vol. 14, No.6, 1994 dissociation term in the model adequately corrects for the decreasing rate of uptake. A similar correc tion has been proposed for the graphical method (Patlak and Blasberg, 1985) , Thus, when day 2 data are not available (as in PET experiments with [11C][3-CIT), method D would presumably be the method of choice to derive a stable outcome mea sure.
The day 2 ratio method is most appropriate for clinical SPECT application. Patients can be injected on day 1 and one scan can be acquired on day 2. This method yields V3/1 , which is linearly related to BP by
Thus, V3/1 could be used as an outcome measure if the nonspecific (V 2 ) is assumed to be identical be tween subjects , In that case, no blood measure ments are needed. This last factor could, however, be easily controlled by measuring the tracer plasma venous concentration at the time of the scan and deriving BP as the C3(t)/f I Ca(t) ratio (Laruelle et a!., 1993a) . Obviously, a more extensive knowledge of the distribution of plasma clearance rates and DA trans porters levels in healthy subjects and patients is needed before implementing this method. The as sumption of sustained equilibrium on day 2 should be further validated by direct measurement of the plasma tracer concentration on day 2. The minimal time requested to reach regional stability after the bolus injection needs to be established in a larger group of subjects. An important question is the ac curacy of this method under conditions of shorter terminal half-lives. Simulations performed using a terminal half-life of 50 h (corresponding to an oc cipital washout rate of 1 %/h) showed that the C3(t)/ CzCt) ratio measured between 1,200 and 1,440 min was within 6% of the true V3/1. Additional simula tions showed that the error was less than 20% for half-lives longer than 10 h (5%/h occipital washout) and increased to unacceptable levels for half-lives shorter than 10 h.
In conclusion, various approaches were used to analyze e 23 I] [3-CIT SPECT experiments in humans. The graphical analysis was found to be potentially affected by the blood flow. Kinetic analysis of day 1 provide stable and well-identified parameters when striatal V 2 was constrained to occipital V 2 and when a slow but significant dissociation term was included in the model (fit D). The stability of day 2 data led to the development of an equilibrium anal ysis that might provide an adequate outcome mea-sure, easily applicable in the clinical setting. How ever, further validation of this approach is needed in a larger group of healthy controls and patients. The reproducibility of these various quantitation approaches is currently investigated with a test/ retest paradigm. The combination of SPECT cam era availability with a simple yet accurate method that does not require arterial blood measurements or repeated scans would certainly increase the clin ical use of this product in the diagnosis and treat ment of Parkinson ' s disease.
